CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
Phase ib study of trastuzumab emtansine (TDM1) in combination with lapatinib and nab-paclitaxel in metastatic HER2-neu overexpressed breast cancer patients: Stela results.
Author
Angel Augusto Rodriguez
Anna Belcheva
+9Â more
Jenny Chee Ning Chang
Joe Ensor
John G. Kuhn
Jorge German Darcourt
Polly Ann Niravath
Tejal Amar Patel
Toniva Boone
Virginia G. Kaklamani
Xiaoxian Li
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Care 001: Multicenter randomized open label phase II trial of neoadjuvant trastuzumabemtansine (T-DM1) in combination with lapatinib and nab-paclitaxel compared with paclitaxel, trastuzumab and pertuzumab in HER 2 neu over-expressed breast cancer patients (TEAL study).
Author
Angel Augusto Rodriguez
Anna Belcheva
+12Â more
Jane Lowe Meisel
Jenny Chee Ning Chang
Joe Ensor
John G. Kuhn
Jorge German Darcourt
Polly Ann Niravath
Roberto R Rosato
Sarah Creamer
Tejal Amar Patel
Toniva Boone
Virginia G. Kaklamani
Xiaoxian Li
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref